Literature DB >> 32761223

Earlier the better: convalescent plasma.

Aaron A R Tobian1, Beth H Shaz2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32761223      PMCID: PMC7414595          DOI: 10.1182/blood.2020007638

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  10 in total

1.  Early safety indicators of COVID-19 convalescent plasma in 5,000 patients.

Authors:  Michael J Joyner; R Scott Wright; DeLisa Fairweather; Jonathon W Senefeld; Katelyn A Bruno; Stephen A Klassen; Rickey E Carter; Allan M Klompas; Chad C Wiggins; John Ra Shepherd; Robert F Rea; Emily R Whelan; Andrew J Clayburn; Matthew R Spiegel; Patrick W Johnson; Elizabeth R Lesser; Sarah E Baker; Kathryn F Larson; Juan G Ripoll; Kylie J Andersen; David O Hodge; Katie L Kunze; Matthew R Buras; Matthew Np Vogt; Vitaly Herasevich; Joshua J Dennis; Riley J Regimbal; Philippe R Bauer; Janis E Blair; Camille M van Buskirk; Jeffrey L Winters; James R Stubbs; Nigel S Paneth; Nicole C Verdun; Peter Marks; Arturo Casadevall
Journal:  J Clin Invest       Date:  2020-06-11       Impact factor: 14.808

2.  Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.

Authors:  Ling Li; Wei Zhang; Yu Hu; Xunliang Tong; Shangen Zheng; Juntao Yang; Yujie Kong; Lili Ren; Qing Wei; Heng Mei; Caiying Hu; Cuihua Tao; Ru Yang; Jue Wang; Yongpei Yu; Yong Guo; Xiaoxiong Wu; Zhihua Xu; Li Zeng; Nian Xiong; Lifeng Chen; Juan Wang; Ning Man; Yu Liu; Haixia Xu; E Deng; Xuejun Zhang; Chenyue Li; Conghui Wang; Shisheng Su; Linqi Zhang; Jianwei Wang; Yanyun Wu; Zhong Liu
Journal:  JAMA       Date:  2020-08-04       Impact factor: 56.272

3.  Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.

Authors:  Judith A Aberg; Nicole M Bouvier; Sean T H Liu; Hung-Mo Lin; Ian Baine; Ania Wajnberg; Jeffrey P Gumprecht; Farah Rahman; Denise Rodriguez; Pranai Tandon; Adel Bassily-Marcus; Jeffrey Bander; Charles Sanky; Amy Dupper; Allen Zheng; Freddy T Nguyen; Fatima Amanat; Daniel Stadlbauer; Deena R Altman; Benjamin K Chen; Florian Krammer; Damodara Rao Mendu; Adolfo Firpo-Betancourt; Matthew A Levin; Emilia Bagiella; Arturo Casadevall; Carlos Cordon-Cardo; Jeffrey S Jhang; Suzanne A Arinsburg; David L Reich
Journal:  Nat Med       Date:  2020-09-15       Impact factor: 53.440

4.  Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

Authors:  Chenguang Shen; Zhaoqin Wang; Fang Zhao; Yang Yang; Jinxiu Li; Jing Yuan; Fuxiang Wang; Delin Li; Minghui Yang; Li Xing; Jinli Wei; Haixia Xiao; Yan Yang; Jiuxin Qu; Ling Qing; Li Chen; Zhixiang Xu; Ling Peng; Yanjie Li; Haixia Zheng; Feng Chen; Kun Huang; Yujing Jiang; Dongjing Liu; Zheng Zhang; Yingxia Liu; Lei Liu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

Review 5.  Deployment of convalescent plasma for the prevention and treatment of COVID-19.

Authors:  Evan M Bloch; Shmuel Shoham; Arturo Casadevall; Bruce S Sachais; Beth Shaz; Jeffrey L Winters; Camille van Buskirk; Brenda J Grossman; Michael Joyner; Jeffrey P Henderson; Andrew Pekosz; Bryan Lau; Amy Wesolowski; Louis Katz; Hua Shan; Paul G Auwaerter; David Thomas; David J Sullivan; Nigel Paneth; Eric Gehrie; Steven Spitalnik; Eldad A Hod; Lewis Pollack; Wayne T Nicholson; Liise-Anne Pirofski; Jeffrey A Bailey; Aaron Ar Tobian
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

6.  Effectiveness of convalescent plasma therapy in severe COVID-19 patients.

Authors:  Kai Duan; Bende Liu; Cesheng Li; Huajun Zhang; Ting Yu; Jieming Qu; Min Zhou; Li Chen; Shengli Meng; Yong Hu; Cheng Peng; Mingchao Yuan; Jinyan Huang; Zejun Wang; Jianhong Yu; Xiaoxiao Gao; Dan Wang; Xiaoqi Yu; Li Li; Jiayou Zhang; Xiao Wu; Bei Li; Yanping Xu; Wei Chen; Yan Peng; Yeqin Hu; Lianzhen Lin; Xuefei Liu; Shihe Huang; Zhijun Zhou; Lianghao Zhang; Yue Wang; Zhi Zhang; Kun Deng; Zhiwu Xia; Qin Gong; Wei Zhang; Xiaobei Zheng; Ying Liu; Huichuan Yang; Dongbo Zhou; Ding Yu; Jifeng Hou; Zhengli Shi; Saijuan Chen; Zhu Chen; Xinxin Zhang; Xiaoming Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-06       Impact factor: 11.205

7.  Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.

Authors:  Michael J Joyner; Katelyn A Bruno; Stephen A Klassen; Katie L Kunze; Patrick W Johnson; Elizabeth R Lesser; Chad C Wiggins; Jonathon W Senefeld; Allan M Klompas; David O Hodge; John R A Shepherd; Robert F Rea; Emily R Whelan; Andrew J Clayburn; Matthew R Spiegel; Sarah E Baker; Kathryn F Larson; Juan G Ripoll; Kylie J Andersen; Matthew R Buras; Matthew N P Vogt; Vitaly Herasevich; Joshua J Dennis; Riley J Regimbal; Philippe R Bauer; Janis E Blair; Camille M van Buskirk; Jeffrey L Winters; James R Stubbs; Noud van Helmond; Brian P Butterfield; Matthew A Sexton; Juan C Diaz Soto; Nigel S Paneth; Nicole C Verdun; Peter Marks; Arturo Casadevall; DeLisa Fairweather; Rickey E Carter; R Scott Wright
Journal:  Mayo Clin Proc       Date:  2020-07-19       Impact factor: 7.616

Review 8.  How did we rapidly implement a convalescent plasma program?

Authors:  Alexandra Budhai; Annie A Wu; Lucette Hall; Donna Strauss; Sarai Paradiso; Jill Alberigo; Christopher D Hillyer; Betsy Jett; Aaron A R Tobian; Evan M Bloch; Bruce S Sachais; Beth H Shaz
Journal:  Transfusion       Date:  2020-06-11       Impact factor: 3.337

9.  Use of convalescent plasma in hospitalized patients with COVID-19: case series.

Authors:  Livia Hegerova; Ted A Gooley; Kelly A Sweerus; Cynthia Maree; Neil Bailey; Megumi Bailey; Vanessa Dunleavy; Krish Patel; Kirsten Alcorn; Rebecca Haley; Jill M Johnsen; Barbara A Konkle; Annamarie C Lahti; Morgan L Alexander; Jason D Goldman; Anne Lipke; Sun-Jung Lim; Mark D Sullivan; John S Pauk; John M Pagel
Journal:  Blood       Date:  2020-08-06       Impact factor: 25.476

10.  Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.

Authors:  Xinyi Xia; Kening Li; Lingxiang Wu; Zhihua Wang; Mengyan Zhu; Bin Huang; Jie Li; Ziyu Wang; Wei Wu; Min Wu; Wanlin Li; Lu Li; Yun Cai; Bakwatanisa Bosco; Aifang Zhong; Xiong Liu; Tangfeng Lv; Zhenhua Gan; Guang Chen; Yunhu Pan; Caidong Liu; Kai Zhang; Xiaoli Xu; Changjun Wang; Qianghu Wang
Journal:  Blood       Date:  2020-08-06       Impact factor: 25.476

  10 in total
  16 in total

1.  Use of Convalescent Plasma in the Management of COVID-19.

Authors:  Dima Dandachi; Suha Abu Khalaf
Journal:  Mo Med       Date:  2021 Mar-Apr

2.  Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.

Authors:  Aaron A R Tobian; Oliver Laeyendecker; Eshan U Patel; Evan M Bloch; William Clarke; Yu-Hsiang Hsieh; Denali Boon; Yolanda Eby; Reinaldo E Fernandez; Owen R Baker; Morgan Keruly; Charles S Kirby; Ethan Klock; Kirsten Littlefield; Jernelle Miller; Haley A Schmidt; Philip Sullivan; Estelle Piwowar-Manning; Ruchee Shrestha; Andrew D Redd; Richard E Rothman; David Sullivan; Shmuel Shoham; Arturo Casadevall; Thomas C Quinn; Andrew Pekosz
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

3.  Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer.

Authors:  Evan M Bloch; Elizabeth P Crowe; Aaron A R Tobian
Journal:  J Infect Dis       Date:  2021-03-03       Impact factor: 5.226

4.  We stand ready … Blood collection organizations and the COVID-19 pandemic.

Authors:  Hany Kamel
Journal:  Transfusion       Date:  2021-05       Impact factor: 3.157

5.  Effect of time and titer in convalescent plasma therapy for COVID-19.

Authors:  Paola de Candia; Francesco Prattichizzo; Silvia Garavelli; Rosalba La Grotta; Annunziata De Rosa; Agostina Pontarelli; Roberto Parrella; Antonio Ceriello; Giuseppe Matarese
Journal:  iScience       Date:  2021-07-22

6.  Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.

Authors:  Harini Natarajan; Andrew R Crowley; Savannah E Butler; Aaron A R Tobian; Margaret E Ackerman; Shiwei Xu; Joshua A Weiner; Evan M Bloch; Kirsten Littlefield; Wendy Wieland-Alter; Ruth I Connor; Peter F Wright; Sarah E Benner; Tania S Bonny; Oliver Laeyendecker; David Sullivan; Shmuel Shoham; Thomas C Quinn; H Benjamin Larman; Arturo Casadevall; Andrew Pekosz; Andrew D Redd
Journal:  mBio       Date:  2021-04-20       Impact factor: 7.786

7.  ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population.

Authors:  Evan M Bloch; Eshan U Patel; Christi Marshall; Kirsten Littlefield; Ruchika Goel; Brenda J Grossman; Jeffrey L Winters; Ruchee Shrestha; Imani Burgess; Oliver Laeyendecker; Shmuel Shoham; David Sullivan; Eric A Gehrie; Andrew D Redd; Thomas C Quinn; Arturo Casadevall; Andrew Pekosz; Aaron A R Tobian
Journal:  Vox Sang       Date:  2021-01-25       Impact factor: 2.996

8.  Convalescent plasma for COVID-19 - encouraging signals of efficacy.

Authors:  Arturo Casadevall; Aaron A R Tobian
Journal:  Br J Haematol       Date:  2021-02-01       Impact factor: 6.998

9.  SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.

Authors:  Sarah E Benner; Eshan U Patel; Oliver Laeyendecker; Andrew Pekosz; Kirsten Littlefield; Yolanda Eby; Reinaldo E Fernandez; Jernelle Miller; Charles S Kirby; Morgan Keruly; Ethan Klock; Owen R Baker; Haley A Schmidt; Ruchee Shrestha; Imani Burgess; Tania S Bonny; William Clarke; Patrizio Caturegli; David Sullivan; Shmuel Shoham; Thomas C Quinn; Evan M Bloch; Arturo Casadevall; Aaron A R Tobian; Andrew D Redd
Journal:  J Infect Dis       Date:  2020-11-13       Impact factor: 5.226

10.  SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy.

Authors:  Harini Natarajan; Andrew R Crowley; Savannah E Butler; Shiwei Xu; Joshua A Weiner; Evan M Bloch; Kirsten Littlefield; Wendy Wieland-Alter; Ruth I Connor; Peter F Wright; Sarah E Benner; Tania S Bonny; Oliver Laeyendecker; David J Sullivan; Shmuel Shoham; Thomas Quinn; H Benjamin Larman; Arturo Casadevall; Andrew Pekosz; Andrew Redd; Aaron Ar Tobian; Margaret E Ackerman
Journal:  medRxiv       Date:  2020-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.